‘Truly Practice Changing’ Trial in Gastroesophageal Cancer

By News Health
2 hours Ago

(MedPage Today) — SAN FRANCISCO — Incorporating the recently approved bispecific antibody zanidatamab (Ziihera) into first-line treatment for HER2-positive gastroesophageal cancer topped trastuzumab plus chemotherapy, a phase III trial showed…

Source link : https://www.medpagetoday.com/meetingcoverage/mgics/119319

Author :

Publish date : 2026-01-07 20:16:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Will Progress on Protecting Young Kids From RSV Be Reversed?

Risky Psychedelic Retreats; Psilocybin for Binge Eating; Winter 'SAD' Routines

Acid Suppressants in Pregnancy Not Linked to Neuropsychiatric Disorders in Kids

Spondyloarthritis: Spinal MRI May Improve Management

Yet Another NIH Leader Resigns; Bhattacharya in the Middle; Whooping Cough Rising

Eye Issues Common With ANCA-Associated Vasculitis